- Tytuł:
-
A phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with
tumor lysis syndrome . - Autorzy:
- Źródło:
- Leukemia & Lymphoma. Mar2023, Vol. 64 Issue 3, p628-638. 11p.
Czasopismo naukowe